Moderna (MRNA) Share-based Compensation Growth (3y) (2021 - 2026)
Moderna (MRNA) Share-based Compensation Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 244.08% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -50.27% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moderna | 22.52 Bn | 17.32 Bn | -566.00 Mn | -70.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.12% |
| Dec 31, 2025 | 22.15% |
| Sep 30, 2025 | 21.32% |
| Jun 30, 2025 | 37.51% |
| Mar 31, 2025 | 37.75% |
| Dec 31, 2024 | 126.34% |
| Dec 31, 2023 | 44.84% |
| Sep 30, 2023 | 51.83% |
| Jun 30, 2023 | 43.58% |
| Mar 31, 2023 | 55.36% |
| Dec 31, 2022 | 45.32% |
| Sep 30, 2022 | 49.85% |
| Jun 30, 2022 | 32.50% |
| Mar 31, 2022 | 33.49% |
| Dec 31, 2021 | 5.35% |
| Sep 30, 2021 | 39.55% |
| Jun 30, 2021 | 34.60% |
| Mar 31, 2021 | 36.29% |